Figure 1. Schematic representation of the integrated logistics made possible by using a targeting hybrid imaging agent.

A) Analysis of tumor biopsy samples using the fluorescent beacon of the imaging agent using flow cytometry. B) Non-invasive tumor visualization using SPECT/CT after radiolabeling of the hybrid agent. Fluorescence imaging enables intraoperative surgical guidance. C) Ex vivo evaluation of tracer distribution using fluorescence imaging and –microscopy after excision of the tumor.